Comparison

Pembrolizumab European Partner

Item no. TMO-T9908-50mg
Manufacturer TargetMol
CASRN 1374853-91-4
Amount 50 mg
Quantity options 100 mg 100 mg 10 mg 10 mg 1 mg 1 mg 25 mg 25 mg 2 mg 2 mg 50 mg 50 mg 5 mg 5 mg
Category
Type Molecules
Specific against other
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias Pembrolizumab(anti-PD-1)
Shipping Condition Cool pack
Available
Manufacturer - Targets
PD-1/PD-L1
Shipping Temperature
Cool pack
Storage Conditions
-20°C
Molecular Weight
149 kDa
Description
Pembrolizumab (MK-3475) is a highly selective humanized monoclonal antibody that antagonizes PD-1. It can block the PD-1 protein on T cells and prevent their interaction with PD-L1 on cancer cells.
Pathways
Apoptosis|||Cell Cycle/Checkpoint|||Immunology/Inflammation

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close